Expect Significant Synergies From Unichem Acquisition, Torrent Pharma Says

Unichem acquisition will be funded 70 percent via debt, says Torrent Pharma’s Samir Mehta.

BQ Desk @bqprime

08 Nov 2017, 02:27 PM IST

Tablets are arranged for a photograph (Photographer: Dhiraj Singh/Bloomberg)

Torrent Pharmaceuticals Ltd. expects to garner significant revenue synergies from its acquisition of Unichem Laboratories Ltd.’s domestic branded business for Rs 3,600 crore.

In an interview with BloombergQuint, Samir Mehta, chairman at Torrent Pharma also outlined the company’s product portfolio, international business outlook and future growth plans.

You can watch the full interview here:

Also Read: Unichem’s Shareholders Will Be Rewarded Adequately, Says Chairman And MD